DA 3003-2

• Description :

  DA 3003-2 is a potent and selectively Cdc25 inhibitor. DA 3003-2 shows antiproliferative activity. DA 3003-2 induces cell cycle arrest at the G2/M phase and increases the expression of P-tyr15 Cdc2. DA 3003-2 has the potential for the research of prostate cancer[1].

• CAS Number :

  [383907-47-9]

• Product Name Alternative :

  NSC663285

• UNSPSC :

  12352005

• Target :

  Phosphatase

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/da-3003-2.html

• Purity :

  98.36

• Solubility :

  DMSO : 150 mg/mL (ultrasonic)

• Smiles :

  O=C(C1=C(C2=O)N=CC=C1)C(NCCN3CCOCC3)=C2Cl

• Molecular Formula :

  C15H16ClN3O3

• Molecular Weight :

  321.76

• References & Citations :

  [1]Nemoto K. G2/M accumulation in prostate cancer cell line PC-3 is induced by Cdc25 inhibitor 7-chloro-6- (2-morpholin-4-ylethylamino) quinoline-5, 8-dione (DA 3003-2) . Exp Ther Med. 2010 Jul;1 (4) :647-650.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, sealed storage, away from moisture and light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported